IL118069A - Monoclonal antibody reactive to human CETP and assay method for human CETP - Google Patents
Monoclonal antibody reactive to human CETP and assay method for human CETPInfo
- Publication number
- IL118069A IL118069A IL11806996A IL11806996A IL118069A IL 118069 A IL118069 A IL 118069A IL 11806996 A IL11806996 A IL 11806996A IL 11806996 A IL11806996 A IL 11806996A IL 118069 A IL118069 A IL 118069A
- Authority
- IL
- Israel
- Prior art keywords
- human cetp
- monoclonal antibody
- assay method
- antibody reactive
- cetp
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/54—F(ab')2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13483695 | 1995-05-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL118069A0 IL118069A0 (en) | 1996-08-04 |
IL118069A true IL118069A (en) | 2000-06-01 |
Family
ID=15137605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11806996A IL118069A (en) | 1995-05-02 | 1996-04-29 | Monoclonal antibody reactive to human CETP and assay method for human CETP |
Country Status (10)
Country | Link |
---|---|
US (2) | US6140474A (cs) |
EP (1) | EP0825259B1 (cs) |
KR (1) | KR100244573B1 (cs) |
AU (1) | AU5515696A (cs) |
CA (1) | CA2219947C (cs) |
DE (1) | DE69635017T2 (cs) |
ES (1) | ES2248808T3 (cs) |
IL (1) | IL118069A (cs) |
IN (1) | IN188167B (cs) |
WO (1) | WO1996034948A1 (cs) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL118069A (en) * | 1995-05-02 | 2000-06-01 | Japan Tobacco Inc | Monoclonal antibody reactive to human CETP and assay method for human CETP |
US20020028469A1 (en) * | 1997-11-14 | 2002-03-07 | Burch Ronald M. | Method of defining genus of chemical compound and method of designing molecules |
JP2000180442A (ja) * | 1998-12-15 | 2000-06-30 | Fuji Photo Film Co Ltd | 血液濾過器 |
US20040018577A1 (en) | 2002-07-29 | 2004-01-29 | Emerson Campbell John Lewis | Multiple hybrid immunoassay |
AT500648B1 (de) * | 2002-08-12 | 2010-03-15 | Igeneon Krebs Immuntherapie | Set zur behandlung von krebspatienten |
EP2257641A1 (en) * | 2008-02-13 | 2010-12-08 | Novartis AG | Farp2 and stk25 and uses thereof |
US9884904B2 (en) * | 2010-03-10 | 2018-02-06 | Hoffmann-La Roche Inc. | Method for purifying polypeptide solutions |
US10233502B2 (en) * | 2011-06-22 | 2019-03-19 | Indiana University Research And Technology Corporation | Compositions for and methods of detecting, diagnosing, and prognosing thymic cancer |
WO2013075040A1 (en) * | 2011-11-16 | 2013-05-23 | The Regents Of The University Of California | Cholesterol ester transfer protein (cetp) inhibitor polypeptide antibodies for prophylactic and therapeutic anti-atherosclerosis treatments |
CN107108720A (zh) | 2014-11-06 | 2017-08-29 | 豪夫迈·罗氏有限公司 | 具有改变的FCRN结合的Fc区变体及其使用方法 |
CN108588101B (zh) * | 2018-04-27 | 2022-03-04 | 苏丹 | 构建同一基因不同表达载体的分子克隆方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5530101A (en) * | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
US5279540A (en) | 1992-09-24 | 1994-01-18 | Davidson Michael H | Method for reducing the risk of atherosclerosis |
JPH06169793A (ja) * | 1992-12-02 | 1994-06-21 | Eiken Chem Co Ltd | モノクローナル抗体 |
JPH07128333A (ja) * | 1993-11-09 | 1995-05-19 | Nippon Koutai Kenkyusho:Kk | コレステリルエステル転送蛋白の免疫測定法 |
IL118069A (en) * | 1995-05-02 | 2000-06-01 | Japan Tobacco Inc | Monoclonal antibody reactive to human CETP and assay method for human CETP |
-
1996
- 1996-04-29 IL IL11806996A patent/IL118069A/xx not_active IP Right Cessation
- 1996-04-30 IN IN782CA1996 patent/IN188167B/en unknown
- 1996-05-01 KR KR1019970707809A patent/KR100244573B1/ko not_active IP Right Cessation
- 1996-05-01 ES ES96912292T patent/ES2248808T3/es not_active Expired - Lifetime
- 1996-05-01 CA CA002219947A patent/CA2219947C/en not_active Expired - Fee Related
- 1996-05-01 EP EP96912292A patent/EP0825259B1/en not_active Expired - Lifetime
- 1996-05-01 AU AU55156/96A patent/AU5515696A/en not_active Abandoned
- 1996-05-01 WO PCT/JP1996/001191 patent/WO1996034948A1/ja active IP Right Grant
- 1996-05-01 US US08/945,646 patent/US6140474A/en not_active Expired - Lifetime
- 1996-05-01 DE DE69635017T patent/DE69635017T2/de not_active Expired - Lifetime
-
2000
- 2000-07-12 US US09/615,404 patent/US6410020B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2219947C (en) | 2007-02-13 |
CA2219947A1 (en) | 1996-11-07 |
DE69635017D1 (de) | 2005-09-08 |
US6140474A (en) | 2000-10-31 |
KR100244573B1 (ko) | 2000-02-15 |
EP0825259A4 (en) | 2001-04-25 |
US6410020B1 (en) | 2002-06-25 |
AU5515696A (en) | 1996-11-21 |
DE69635017T2 (de) | 2006-06-01 |
KR19990008283A (ko) | 1999-01-25 |
EP0825259A1 (en) | 1998-02-25 |
EP0825259B1 (en) | 2005-08-03 |
IN188167B (cs) | 2002-08-31 |
WO1996034948A1 (fr) | 1996-11-07 |
ES2248808T3 (es) | 2006-03-16 |
IL118069A0 (en) | 1996-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0870826A4 (en) | NEW PROTEINS AND MONOCLONAL ANTIBODIES AGAINST THESE | |
EP0759071A4 (en) | MONOCLONAL ANTIBODIES AGAINST WT1 AND METHOD FOR THEIR USE | |
EP0921815A4 (en) | THERAPEUTIC USES OF HUMANIZED ANTIBODIES AGAINST ALPHA-4 INTEGRIN | |
PL311926A1 (en) | Anti-alphav-integrinic monoclonal antibodies | |
IL111926A0 (en) | Humanized antibodies and uses thereof | |
IL136335A0 (en) | Monoclonal human natural antibodies | |
EP0809806A4 (en) | MONOCLONAL ANTIBODIES AGAINST SURFACE ANTIGENS OF OSTEOGENIC CELLS | |
IL118069A (en) | Monoclonal antibody reactive to human CETP and assay method for human CETP | |
AU6220096A (en) | Method for the simultaneous detection of different antibodies and/or antigens | |
AU3923293A (en) | Human monoclonal antibodies and methods for human monoclonal antibody production | |
AU4274293A (en) | Human monoclonal antibodies against cytomegalovirus and method for preparation thereof | |
PL320610A1 (en) | Fragments of monoclonal antibodies of immunosuppressive activity | |
AU5688596A (en) | Anti-cd14 antibodies for use in the induction of il-10 secre tion | |
IL109232A0 (en) | Human monoclonal antibodies and processes and materials for making such antibodies | |
IL102088A0 (en) | Me20:monoclonal antibodies and antigen for human melanoma | |
AU9143991A (en) | Monoclonal antibody op-g2 and method of use | |
AU6777594A (en) | Human monoclonal antibodies to human cytomegalovirus, and methods therefor | |
ZA969164B (en) | A method relating to the preparation of amorphous samples and means therefor | |
AU4910893A (en) | Method for the simultaneous determination of antigens and antibodies | |
EP0407586A4 (en) | Human monoclonal antibody and process for its preparation | |
EP1012605A4 (en) | IMMUNOLOGICAL ANALYSIS PROCESS USING A MONOCLONAL ANTIBODY REACTING TO THE INNOVATIVE ENZYME OF HUMAN ORIGIN | |
GB9519460D0 (en) | Polyclonal antibodies and their use | |
GB9506425D0 (en) | New uses of monoclonal antibodies | |
AU715828C (en) | Novel monoclonal antibody and method of immunological analysis of e-D-dimer and e-DD/E complex | |
IL110178A (en) | Monoclonal antibodies specific to antigen-human MHC complex |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |